inclusion criteria: - persons aged ≥12 years if receiving primary two-dose mrna covid-19 vaccine series or persons aged ≥18 years if receiving a third mrna covid-19 vaccine dose according to fda authorization or approval and acip recommendation. note: receipt of an mrna covid-19 vaccine within 8 hours of enrollment is permitted - english or spanish literate - intention of receiving influenza vaccine and covid-19 vaccine based on acip-cdc guidelines - willing to provide written informed consent - intention of being available for entire study period and complete all relevant study procedures, including follow-up phone calls and clinic visits

inclusion criteria: - persons aged ≥12 years if receiving primary two-dose mrna covid-19 vaccine series or persons aged ≥18 years if receiving a third mrna covid-19 vaccine dose according to fda authorization or approval and acip recommendation. note: receipt of an mrna covid-19 vaccine within 8 hours of enrollment is permitted - english or spanish literate - intention of receiving influenza vaccine and covid-19 vaccine based on acip-cdc guidelines - willing to provide written informed consent - intention of being available for entire study period and complete all relevant study procedures, including follow-up phone calls and clinic visits

inclusion criteria: - persons aged ≥12 years - english or spanish literate - intention of receiving influenza vaccine and covid-19 vaccine based on acip-cdc guidelines - willing to provide written informed consent - intention of being available for entire study period and complete all relevant study procedures, including follow-up phone calls and clinic visits

inclusion criteria: - persons aged ≥12 years - english or spanish literate - intention of receiving influenza vaccine and covid-19 vaccine based on acip-cdc guidelines - willing to provide written informed consent - intention of being available for entire study period and complete all relevant study procedures, including follow-up phone calls and clinic visits